logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > China Stock

Xinjiang Guotong Pipeline (002205.SZ) issues a profit warning, expecting a net loss of between 60 million and 85 million yuan in 2024.

date
19:57 21/01/2025
avatar
GMT Eight
China National Technology Co., Ltd. (002205.SZ) issued an announcement, and the company expects the net profit attributable to the shareholders of the listed company in 2024...
Xinjiang Guotong Pipeline (002205.SZ) announced that the company expects a net loss belonging to the shareholders of the listed company of 60 to 85 million yuan in 2024.
Related Articles
China Stock
Brightgene Bio-Medical Technology Co., Ltd. (688166.SH) is expected to be selected for part of the national drug procurement program.
China Stock
ChengDu Sheng Nuo Biotec (stock ticker 688117.SH) plans to be selected in part for the new round of follow-up purchases.
US Stock
Refinery profits soar but struggle against the cold winter of oil and gas prices! Total (TTE.US) Q4 profits fall short of expectations and announces a reduction in stock buyback size.
Brightgene Bio-Medical Technology Co., Ltd. (688166.SH) is expected to be selected for part of the national drug procurement program.
China Stock
ChengDu Sheng Nuo Biotec (stock ticker 688117.SH) plans to be selected in part for the new round of follow-up purchases.
China Stock
Refinery profits soar but struggle against the cold winter of oil and gas prices! Total (TTE.US) Q4 profits fall short of expectations and announces a reduction in stock buyback size.
US Stock
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
icon
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
icon
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
icon
07/02/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.